MedTrace Logo

Premature Newborns Treated With Less Invasive Surfactant Administration Under Heated Humidified High-flow

NCT06398691 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2024-05-03

No results posted yet for this study

Summary

Nasal Continuous Airway Pressure (CPAP) or Heated humidified high-flow Air support with nasal cannula (HHHFNC) are among the most commonly used non-invasive respiratory support methods. The purpose of this prospective study was to compare vital findings, blood gas parameters, perfusion index (PI) and plethysmographic variability index (PVI) values in premature infants treated with less invasive surfactant administration (LISA) under HHHFNC or CPAP.

Conditions

  • Respiratory Disease
  • Newborn Rds

Interventions

DEVICE

Nazal CPAP

DEVICE

Heated humidified high-flow air support with nasal cannula

Sponsors & Collaborators

  • Hacettepe University

    lead OTHER

Principal Investigators

  • MELEK BUYUKEREN · Hacettepe University, Neonatology

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
1 Minute
Max Age
3 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-10
Primary Completion
2017-11-23
Completion
2017-12-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06398691 on ClinicalTrials.gov